Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study Article

Chabot, Pierre, Hsia, Te-Chun, Ryu, Jeong-Seon et al. (2017). Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study . JOURNAL OF NEURO-ONCOLOGY, 131(1), 105-115. 10.1007/s11060-016-2275-x

Open Access International Collaboration

cited authors

  • Chabot, Pierre; Hsia, Te-Chun; Ryu, Jeong-Seon; Gorbunova, Vera; Belda-Iniesta, Cristobal; Ball, David; Kio, Ebenezer; Mehta, Minesh; Papp, Katherine; Qin, Qin; Qian, Jane; Holen, Kyle D; Giranda, Vince; Suh, John H

sustainable development goals

authors

publication date

  • January 1, 2017

webpage

published in

keywords

  • Brain metastases
  • CLINICAL-TRIALS
  • Clinical Neurology
  • GRADED PROGNOSTIC ASSESSMENT
  • Life Sciences & Biomedicine
  • MOTEXAFIN GADOLINIUM
  • Neurosciences & Neurology
  • Non-small cell lung cancer
  • Oncology
  • PARP inhibitor
  • POLYMERASE INHIBITOR
  • QUALITY-OF-LIFE
  • RANO GROUP
  • RESPONSE CRITERIA
  • Randomized clinical trial
  • SINGLE METASTASES
  • SOLID TUMORS
  • STEREOTACTIC RADIOSURGERY
  • Science & Technology
  • Veliparib
  • Whole-brain radiation therapy

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 105

end page

  • 115

volume

  • 131

issue

  • 1